← Eichor
Condition: Net Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Net

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036
Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe)
NA · 1 location(s) · Saint Vincent's Hospital, Korea · NCT05971225
61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
Phase 1/Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06455358
Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Stu
Phase N/A · 1 location(s) · Centre Hospitalier de Martigues · NCT07560423
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide
Phase 3 · 1 location(s) · Sarfez Pharmaceuticals, Inc. · NCT07223502
Sequencing in Inflammatory Bowel Diseases (IBD) Therapy: "the Latium Net".
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06603337
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Phase 3 · 51 location(s) · Axsome Therapeutics, Inc. · NCT07398417
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
NA · 1 location(s) · Diabetes Solutions International · NCT06939413
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Phase N/A · 2 location(s) · Boston Children's Hospital · NCT03848923
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.
NA · 1 location(s) · Physician Affiliate Group of New York · NCT06876831
Multi-observational Study for the Early Identification of Autism Spectrum Disorder (ASD) and Other Neurodevelopmental Di
Phase N/A · 5 location(s) · Istituto Superiore di Sanità · NCT06915805
68Ga-DOTA-TATE PET/CT Imaging in NETs
Phase 3 · 2 location(s) · Centre de recherche du Centre hospitalier universitaire de S · NCT04847505
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT06505395
Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
NA · 4 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06986148
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer S
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06760754
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Interve
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06843720
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Edwin Posadas, MD · NCT06888102
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
Phase 2 · 2 location(s) · Peking University · NCT05165407
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · 117 location(s) · Exelixis · NCT06943755
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
NA · 15 location(s) · University Hospital, Bordeaux · NCT07119970
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Phase N/A · 20 location(s) · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendoc
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06427798
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
Phase 3 · 1 location(s) · University Hospital, Strasbourg, France · NCT03368092
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
NA · 2 location(s) · Xuanwu Hospital, Beijing · NCT07552610
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Phase 2 · 4 location(s) · Shanghai Chest Hospital · NCT07357623
Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06356467
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT06510868
Mobile Application to Collect PRO Data in NET Patients
Phase N/A · 1 location(s) · King's College Hospital NHS Trust · NCT04324502
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Phase 3 · 65 location(s) · Novartis Pharmaceuticals · NCT06784752
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.